KRAS and viral infectious disease: The anti-ZIKV-NS3/4A sequence expressed in our transgenic mosquito line was selected based on previous findings in which mosquitoes were highly protected against ZIKV (PRVABC59) when intrathoracically injected (prior to virus infection) with dsRNAs derived from the viral sequence [29].